Binding of β-carbolines at 5-HT2 serotonin receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 24, 2003, Pages 4421-4425

  Grella, Brian ^a   Teitler, Milt ^b   Smith, Carol ^b   Herrick Davis, Katharine ^b   Glennon, R A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHOXYHARMALAN; 7 METHOXY 1,2,3,4 TETRAHYDRO BETA CARBOLINE; BETA CARBOLINE DERIVATIVE; HARMALAN; HARMALINE; PSYCHEDELIC AGENT; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RAT; SUBSTITUTION REACTION;

EID: 0345358479     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.09.027     Document Type: Article

References (27)

1. For a general overview, see Sessions IV and V on hallucinogenic snuffs and concoctions in: Efron, D.; Holmstedt, B.; Kline, N., Eds.; Ethnopharmacologic Search for Psychoactive Drugs; Raven: New York, 1979; p 231.
2. Callaway J.C., McKenna D.J., Grob C.S., Brito G.S., Raymon L.P., Poland R.E., Andrade E.N., Andrade E.O., Mash D.C. J. Ethnopharmacol. 65:1999;243.
3. Riba J., Rodriguez-Fornells A., Urbano G., Morte A., Antonijoan R., Montero M., Callaway J.C., Barbanoj M.J. Psychopharmacology. 154:2001;85.
4. Shulgin, A.; Shulgin, A. Tihkal; Transform: Berkeley, CA, 1997; p 444 and 551.
5. Grella B., Dukat M., Young R., Teitler M., Herrick-Davis K., Gauthier C.B., Glennon R.A. Drug Alcohol Depend. 50:1998;99.
6. Glennon, R. A. In Foye's Principles of Medicinal Chemistry; Williams, D. A.; Lemke, T. M., Eds.; Lippincott, Williams & Wilkins: Philadelphia, 2002; p 434.
7. Glennon R.A. Life Sci. 29:1981;861.
8. Hoyer D., Hannon J.P., Martin G.R. Pharmacol. Biochem. Behav. 71:2002;533.
9. Glennon R.A., Dukat M., Grella B., Hong S.-S., Costantino L., Teitler M., Smith C., Egan C., Davis K., Mattson M.V. Drug Alcohol Depend. 60:2000;121.
10. Glennon R.A., Young R., Jacyno J.M., Slusher M., Rosecrans J.A. Eur. J. Pharmacol. 86:1983;453.
11. Hong S., Dukat M., Teitler M., Egan C., Dupre A., Herrick-Davis K., Glennon R.A. Med. Chem. Res. 9:1999;374.
12. Kim H., Sablin S.O., Ramsay R.R. Arch. Biochem. Biophys. 337:1997;137. and references therein.
13. Bagley M., Moody C., Pepper A. Tetrahedron. Lett. 41:2000;6901.
14. Still I.W.J., Strautmanis J.R. Tetrahedron Lett. 30:1989;1041.
15. Schumacher R.W., Davidson B. Tetrahedron. 55:1999;935.
16. Yamada F., Saida Y., Somei M. Heterocycles. 24:1986;2619.
17. Sotomayor N., Dominquez E., Lete E. Tetrahedron. 51:1995;12721.
18. NIMH PDSP: http://pdsp.cwru.edu/ .
19. Husbands S.M., Glennon R.A., Gorgerat S., Gough R., Tyacke R., Crosby J., Nutt D.J., Lewis J.W., Hudson A.L. Drug Alcohol Depend. 64:2001;203.
20. 9.
21. Compounds 25 oxalate (mp 203-205 °C from iPrOH), 26 hydrochloride (mp 127-129 °C from iPrOH) and 27 oxalate (mp 179-182 °C from MeOH) analyzed within 0.4% of theory for C, H, and N.
22. Takayama H., Kurihara M., Kitajima M., Said I.M., Aimi N. Tetrahedron. 56:2000;3145.
23. Palmisano G., Danieli B., Lesma G., Passarella D. Tetrahedron. 45:1989;3583.
24. Still I.W.J., Strautmanis J.R. Can. J. Chem. 68:1990;1408.
25. Repke D.B., Ferguson W.J. J. Heterocycl. Chem. 19:1982;845.
26. Burov Y.V., Zagorevskii V.A., Zhukov V.N., Novikova N.V., Silenko I.D. Pharm. Chem. J. (Engl. Trans.). 17:1983;559.
27. Spath E., Lederer E. Chem. Ber. 63B:1930;2102.